• Login
    View Item 
    •   Plemochoe Home
    • Articles / Άρθρα
    • School of Medicine
    • Department of Medicine
    • View Item
    •   Plemochoe Home
    • Articles / Άρθρα
    • School of Medicine
    • Department of Medicine
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of PlemochoeCommunities & CollectionsTitlesAuthorsBy Issue DateSubjectsThis CollectionTitlesAuthorsBy Issue DateSubjects

    My Account

    LoginRegister

    Benzo(α)pyrene-induced up-regulation of CYP1A2 gene expression: Role of adrenoceptor-linked signaling pathways

    Thumbnail
    View/Open
    Publisher version (Access full-text PDFOpen Access)
    Publisher version (Check access options)
    Check access options
    Date
    2006-06-20
    Author
    Konstandi, Maria
    Kostakis, Dimitris
    Harkitis, Panagiotis
    Johnson, Elizabeth O.
    Marselos, Marios
    Adamidis, Konstantinos
    Lang, Matti
    Metadata
    Show full item record
    Abstract
    CYP1A2, a principal catalyst for metabolism of various therapeutic drugs and carcinogens, among others, is in part regulated by the stress response. This study was designed to assess whether catecholamines and in particular adrenergic receptor-dependent pathways, modulate benzo(α)pyrene (B(α)P)-induced hepatic CYP1A2. To distinguish between the role of central and peripheral catecholamines in the regulation of CYP1A2 induction, the effect of central and peripheral catecholamine depletion using reserpine was compared to that of peripheral catecholamine depletion using guanethidine. The effects of peripheral adrenaline and L-DOPA administration were also assessed. The results suggest that alterations in central catecholamines modulate 7-methoxyresorufin O-demethylase activity (MROD), CYP1A2 mRNA and protein levels in the B(α)P-induced state. In particular, central catecholamine depletion, dexmedetomidine-induced inhibition of noradrenaline release and blockade of α1-adrenoceptors with prazosin, up-regulated CYP1A2 expression. Phenylephrine and dexmedetomidine-induced up-regulation may be mediated, in part, via peripheral α1- and α2-adrenoceptors, respectively. On the other hand, the L-DOPA-induced increase in central dopaminergic activity was not followed by any change in the up-regulation of CYP1A2 expression by B(α)P. Central noradrenergic systems appeared to counteract up-regulating factors, most likely via α1- and α2-adrenoceptors. In contrast, peripheral alpha- and beta-adrenoceptor-related signaling pathways are linked to up-regulating processes. The findings suggest that drugs that bind to adrenoceptors or affect central noradrenergic neurotransmission, as well as factors that challenge the adrenoceptor-linked signaling pathways may deregulate CYP1A2 induction. This, in turn, may result in drug-therapy and drug-toxicity complications.
    URI
    https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33744526253&origin=inward
    https://repo.euc.ac.cy/handle/123456789/841
    DOI
    10.1016/j.lfs.2006.01.012
    Collections
    • Department of Medicine

    entitlement

    Contact us

    Tel: +357 22 713000
    Fax: +357 22 662051
    Use contact form

    Find us

    European University Cyprus
    6, Diogenis Str., Engomi,
    P.O. Box: 22006, 1516 Nicosia-Cyprus
    View location map

    Connect with us

    Send your request to us

    Request Info
     
    • Contact us
    • Find us
    • Connect with us
    • Request Info
    © 2017 European University Cyprus, All Rights Reserved